Background: Acute kidney injury (AKI) in HIV-infected patients in sub-Saharan Africa is a common cause of hospitalisation and is associated with high morbidity and mortality. There is a paucity of comparative data regarding the outcomes of AKI in those patients with and without HIV infection from the African continent. Methods: This was a single-centre retrospective study of all consecutive adult patients with AKI referred to the renal unit at Tygerberg Hospital for the period January 2015 to December 2016. The diagnosis of AKI required evidence of the following: a recent normal serum creatinine and/or normal kidney sizes on ultrasound examination and/or granular casts on urine microscopy. Kaplan-Meier curves and logistic regression were used to assess survival and identify factors predicting mortality. Results: We identified a total of 291 patients with AKI of whom 116 (40%) were HIV positive. HIV-positive patients had a mortality rate of 34.5% vs. 29.1% in the HIV-negative patients (P = 0.34). At hospital admission, HIV-positive patients had a higher admission serum creatinine (551 μmol/L vs. 190 μmol/L, P < 0.01). Of those who died, the HIV-positive patients were younger (41 vs. 52 years, P < 0.01), predominantly Black (87.5% vs. 23.5%, P < 0.01) and were mostly admitted to medical wards (92.5% vs. 41.2%, P < 0.01). There was no difference in mortality related to the use of renal replacement therapy (P = 0.50). Logistic regression identified mixed ancestry (OR 2.47, P = 0.02), HIV infection (OR 2.69, P < 0.01) and surgical ward admission (OR 2.05, P = 0.03) as predictors of death. Conclusions: In-hospital mortality of AKI was high, and HIV infection was associated with a greater risk of death. This may be the result of late presentation of both the AKI as well as the HIV infection.
care system [6, 7] . The reported incidence of AKI in HIVinfected persons ranges from 2.7 to 5.9 per 100 personyears with higher rates occurring in those recently diagnosed with HIV. The associated mortality is as high as 27-33% [8] .
Risk factors for AKI include low CD4+ T-cell counts. Counts of < 200 cells/mm 3 was one of the most important predictors of morbidity and mortality related to AKI in HIVinfected patients. Decreasing levels of CD4+ T-cell counts have been associated with an increase in the incidence of AKI [9, 10] . Other risk factors include AIDS-defining illnesses, chronic liver disease due to hepatitis B and C, and nephrotoxicity related to highly active antiretroviral therapy (HAART) [4] . Many South African patients present late and usually develop AKI as a complication of diarrhoeal disease or opportunistic infections such as tuberculosis [11] . Druginduced nephrotoxicity related to agents such as tenofovir, rifampicin and amphotericin B are other common causes of AKI. Less common causes include thrombotic microangiopathies and the use of traditional remedies [12] . A mortality rate of 45.5% was observed among adult South African patients presenting with AKI who report the use of traditional medicines [13, 14] .
AKI is the most frequent organ failure in the setting of severe sepsis, with large multicentre studies suggesting that 40% of all AKI in critically ill patients could be attributed to severe sepsis [15, 16] . A local study reported that 43.6% of AKI in HIV-infected patients was due to sepsis [17] . An earlier study, conducted during the pre-HAART era at Tygerberg Hospital, reviewed AKI outcomes in an intensive care unit (ICU) over one year and identified only 3 of 46 patients who were HIV positive. This likely reflected the local practice at the time not to admit HIV-infected patients to the ICU due to nihilism regarding the overall prognosis [18] .
Morbidity and mortality have been demonstrated to be higher in those with HIV who develop AKI [8, 19, 20] . A study of the long-term consequences of AKI reported high rates of subsequent cardiovascular disease, end-stage renal disease and increased mortality [21] . In the developed world, the incidence of AKI and HIV-associated nephropathy (HIVAN) has decreased substantially as a result of early administration of HAART.
Much work has been done regarding HIVAN and HIVrelated CKD; however, there remains a paucity of data regarding AKI and the outcomes of renal replacement therapy (RRT) in the HIV-infected as compared to HIVuninfected patients. In this paper we report on a cohort of patients with AKI at a tertiary hospital in South Africa and provide mortality data based on HIV serological status.
MEtHODs
This was a retrospective, cohort study of patients with AKI admitted to Tygerberg Hospital from 1 January 2015 to 31 December 2016. The hospital is a 1380-bed, public sector teaching hospital in Cape Town and provides secondary and tertiary level care to approximately 1.5 million people in the Western Cape province of South Africa. It is one of two tertiary hospitals in the province responsible for providing acute and chronic adult dialysis services. The modality of dialysis most frequently employed is intermittent haemodialysis. Patients who are haemodynamically unstable are offered slow, low-efficiency dialysis (SLED). Haemodialysis is initiated at the discretion of the attending nephrologist and in most cases this is when traditional indications such as refractory hyperkalaemia or pulmonary oedema have arisen.
This study included all adult patients (≥ 18 years) referred to the Division of Nephrology with AKI. The Kidney Disease: Improving Global Outcomes (KDIGO) criteria for AKI staging was not used because only 105 patients (36%) had information on baseline kidney function available. Most of the patients had community-acquired AKI and presented with established AKI at the time of referral. Urine output data were also not available for many of the patients. Therefore, the diagnosis of AKI was determined based on the following information: (1) where available, a normal serum creatinine concentration and an estimated glomerular filtration rate of > 60 mL/min/1.73 m 2 in the preceding 3 months and/or (2) normal kidney sizes by ultrasound examination (>100 mm in length) and/or (3) the documentation of granular casts on urine microscopy. Patients were excluded if they had CKD or evidence of glomerular disease.
Data that were extracted from clinical files included demographics, AKI diagnosis, additional comorbidities, administration of HAART, use of renal replacement therapy versus conservative management, the ward to which the patient was admitted (medical versus surgical), and laboratory data including serum creatinine and CD4+ T-cell counts.
Patients were divided into two groups: HIV positive and HIV negative. These groups were further subdivided into those that did and did not receive RRT. Differences in mortality between these groups were compared as a primary endpoint.
All numerical data with a normal distribution were described using means ± standard deviations. Non-normal data were reported as medians and interquartile ranges (IQR). The chi-squared test was used to analyse mortality in different groups. Univariable and multivariable logistic regressions were used to identify predictors of death. The t-test was employed to compare the means of continuous data where the data had a normal distribution. Where data did not have a normal distribution, the Mann-Whitney U test was used. Statistical significance was set at a P value of < 0.05.
Permission to perform this study was granted by the Health Research Ethics Committee at Stellenbosch University (approval number S17/01/006) and was conducted in accordance with the Declaration of Helsinki.
rEsULts
A total of 291 cases of AKI were identified. Of these, 116 (40%) were HIV positive. At baseline, the median age was 39 years (IQR 32-46 years), and in the HIV-positive and HIV-negative groups it was 38 years (IQR 32-46 years) and 42 years (IQR 29-56 years), respectively (P = 0.06). One hundred and forty-seven patients (51%) were female, with no significant difference between the groups (P = 0.27). More patients in the HIV-positive group were Black than in the HIV-negative group (90.5% versus 40.6%, respectively, P < 0.01). See Table 1 .
Approximately half (155 patients, 53%) of the patients had comorbid diseases. Non-communicable diseases were more common in HIV-negative cases. Hypertension occurred in 7.8% of HIV-positive patients as compared to 18.3% of HIV-negative patients (P = 0.01). More HIV-infected patients had a diagnosis of tuberculosis than those who were HIV-negative (19.0% versus 2.9%, respectively, P < 0.01).
Regarding baseline laboratory data, the overall median serum creatinine at admission was 240 μmol/L (IQR 114-656 μmol/L). In the HIV-positive group, the median creatinine on admission was much higher at 552 μmol/L (IQR 173-837 μmol/L) than in the HIV-negative group at 190 μmol/L (IQR 104-416 μmol/L, P < 0.01). The overall median serum creatinine at the start of renal replacement therapy was 738 μmol/L (IQR 575-1112.5 μmol/L), with the HIV-positive group having a median creatinine of 923 μmol/L (IQR 61-1221 μmol/L) as compared to the HIV-negative group of 722 μmol/L (IQR 559-1044 μmol/L, P = 0.11). At hospital discharge, the overall median creatinine concentration was 120 μmol/L (IQR 83-181 μmol/L), with the HIV-positive group having a median value of 137 μmol/L (IQR 93-194 μmol/L) as compared to the HIV-negative group of 108.5 μmol/L (IQR 77-169 μmol/L, P = 0.06). The median CD4+ T-cell count was 132 cells/mm 3 in the HIV-positive group. See Table 1 .
The most common causes of AKI in the HIV-positive patients included pneumonia (27%) and diarrhoeal disease (22%), whereas pneumonia (14%), rhabdomyolysis (19%) and obstetric (11%) aetiologies predominated in the HIVnegative patients. All the patients with cardiac failure were HIV negative.
The leading category of AKI was ischaemic acute tubular necrosis (ATN) (46%), followed by septic ATN (38%).
More HIV-positive patients had septic ATN than the HIVnegative group (53% versus 27%, P < 0.01). Other causes of AKI included toxic ATN (13%), acute tubulointerstitial nephritis (3%) and pre-renal azotaemia (0.7%). Table 2 .
Overall mortality was higher in males (53/91, 58%) and more males in the HIV-positive group died than in the HIV-negative group (73% versus 47%, P = 0.02). Black patients represented approximately half of the overall mortality with the overwhelming majority being HIV positive (88% versus 24%, P < 0.01). The mortality rate was highest for those patients in the medical wards (58 patients, 64%) with most HIV positive patients (93%) dying in the medical wards as compared to most HIV-negative patients dying in the surgical wards (57%, P < 0.01). There was no difference in survival between those who received and those who did not receive RRT. See Figure 1C [24] . These studies had relatively lower mortality rates despite patients being older, having more non-communicable diseases and being mostly HIV uninfected. For patients who developed hospital-acquired AKI, the earlier identification and initiation of treatment may have resulted in improved outcomes. Most of the patients in our study had community-acquired AKI and late presentation may have contributed to poorer outcomes.
We found no difference in crude mortality between HIVpositive and HIV-negative patients. Few studies have reported direct comparisons. A 2012 systematic review concluded that there were insufficient data for this purpose [25] . More recently, some studies from South Africa have reported on these outcomes. One of these studies compared the outcomes of AKI in critically ill adult patients treated with continuous RRT and reported very high 90day mortality rates in the HIV-positive patients (60% vs. 10%) [26] . This was thought to be related to late presentation. The lower mortality in our study is probably due to the inclusion of patients who had AKI but recovered kidney function without the need for dialysis, the inclusion of less critically ill patients and our focusing on only inhospital mortality. A Johannesburg study reported slightly higher in-hospital mortality rates than in our study [27] . This study included patients with chronic kidney disease, which may have affected mortality. We identified HIV as an independent predictor of death. The reason for this is uncertain but may be related to late presentation of both the AKI as well as the HIV infection.
We found no difference in mortality related to RRT. A study of HIV-positive patients with AKI requiring dialysis noted that patients who died had lower CD4+ counts, fewer dialysis days as well as shorter length of hospital stay relative to those who recovered kidney function or remained dialysis-dependent [17] . Our findings support the conclusions of others [17, 27] that HIV-infected patients with AKI should be considered for acute dialysis support because their outcomes are similar to those of HIV-negative patients with AKI.
Most of the HIV-positive patients who died were relatively young, Black, male, predominantly admitted to medical wards and had septic AKI. These findings were nearly identical to those documented by other South African studies [17, 26, 27] . The median CD4+ count at baseline was 132 cells/mm 3 , indicating late HIV diagnosis. A low CD4+ count is known to be a strong risk factor for the development of AKI as well as death [9, 17] . Our study also found a higher mortality when CD4+ counts were less than 200 cells/mm 3 .
aKi in South african patients with HiV infection [28] . Since most of the HIV-positive patients who died had CD4+ counts less than 200 cells/mm 3 , it is likely that the late diagnosis of infection was a major factor contributing to this risk. Most of the surgical patients who died were HIV negative; however, these cases were older, had more comorbidities, and were predominantly admitted to the surgical ICU. AKI in this sub-group of critically ill patients was associated with poor outcomes.
We found that ATN was the most common cause of AKI with septic ATN as the dominant cause in the case of HIVinfected patients whereas ischaemic ATN predominated in the HIV-negative patients. This finding was comparable to other studies [17, 27, 29] services is at their peripheral hospitals where treatment, such as a fluid challenge, is initiated. Only if the response to therapy is judged as poor, or the referring physician anticipates that RRT may soon be needed, are patients referred to our facility for possible dialysis. Therefore, many patients with pre-renal azotaemia do not reach our facility because they recover kidney function at their peripheral hospitals and are not referred.
The serum creatinine concentration at the time of presentation was much higher in the HIV-positive patients. Difficulty in accessing healthcare facilities, delays in diagnosis and transfer to tertiary centres are some of the issues that contribute to late presentation. The median serum creatinine concentration at initiation of RRT was not different between the HIV-positive and HIV-negative groups. Arendse et al. reported a pre-dialysis serum creatinine value of 998 μmol/L, which was similar to our patients at the time dialysis was started [17] . In general, due to resource constraints, the initiation of acute dialysis in the South African public sector is usually delayed until more traditional indications have evolved. This practice may vary within centres, from one nephrologist to the next, as well as between the public and private healthcare sectors.
LIMItAtIONs
This was a single-centre, retrospective study. We could not define AKI using more contemporary staging criteria such as the KDIGO or Acute Kidney Injury Network (AKIN) criteria because most of the patients included did not have baseline kidney function available and urine output was not well monitored. Only referrals to our service were assessed. Patients who were not referred may either have died or had mild injury that did not require referral. This may have influenced mortality outcomes. Also, we were unable to score the severity of the illness at presentation and therefore were unable to comment on the effect that this may have had on outcomes. Finally, since this study was conducted in a public sector hospital, mortality outcomes may differ from those of the private sector due to differences in case mix as well as variations in practice.
cONcLUsIONs
In patients with AKI, there was no difference in crude mortality rates based on HIV status or the need for RRT. However, HIV infection was associated with increased mortality. This may be related to late presentation of both the HIV diagnosis as well as the AKI.
aKi in South african patients with HiV infection 
